Sign in
4

Changes in Ownership

Oruka Therapeutics, Inc. Filed Acc 0001209191-16-127439

Options or other derivatives

  • Pres. & Chief Executive Offic acquired 82,600 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Table II: Derivative

Insider Date Transaction Shares Price Value Exercise Expires Underlying Owned after D/I
BRISTOW MICHAEL R Pres. & Chief Executive Offic 2016-06-09 Grant or award · Stock Option (right to buy) +27,200 27,200 D: show line 1 in the form
BRISTOW MICHAEL R Pres. & Chief Executive Offic 2016-06-09 Grant or award · Stock Option (right to buy) +55,400 55,400 D: show line 2 in the form
Loading xslF345X03/doc4.xml…